Back to Search
Start Over
The SpyCatcher-SpyTag interaction mediates tunable anti-tumor cytotoxicity of NK cells.
- Source :
-
Molecular Immunology . Jan2024, Vol. 165, p11-18. 8p. - Publication Year :
- 2024
-
Abstract
- Chimeric antigen receptor (CAR)-modified T and NK cell immunotherapy is a promising approach for cancer treatment. Due to the lack of tunability in anti-tumor activity, conventional CAR therapies have limited efficacy at low tumor antigen densities. To tune the CAR response to tumor cell surface antigens, we have developed a split CAR using the SpyCatcher-SpyTag system. The SpyCatcher serves as the ectodomain to constitute a SpyCatcher-CAR (SpyCAR), while SpyTag is attached to the antibodies that recognize tumor antigens. With dimerization mediated by SpyCatcher and SpyTag, the number and activation level of SpyCARs recruited by tumor antigens depends on the SpyTag number in the "antibody-SpyTag" fusion protein. The results demonstrated that the increasing number of SpyTags effectively enhanced the cytotoxicity of SpyCAR-NK92 cells against target cells. The development of SpyCAR with tunable cytotoxicity provides a novel strategy for CAR-based tumor immunotherapies. • The SpyCAR system was developed based on non-covalent SpyCatcher-SpyTag. • The SpyCatcher-SpyTag interaction mediates enhanced cytotoxicity of SpyCAR-NK92 cells. • The cytotoxicity of SpyCAR-NK92 cells is in a SpyTag number-dependent manner. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01615890
- Volume :
- 165
- Database :
- Academic Search Index
- Journal :
- Molecular Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 174667347
- Full Text :
- https://doi.org/10.1016/j.molimm.2023.12.001